Catalyst Wire Dossier Catalyst Wire Dossier

REPEVAX

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for REPEVAX, covering 2014-11-26 to 2017-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old [Phase 3]

See pricing